Do you want to read an article? Please log in or register.
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies
Further Publications
Related content
Further Publications
Precision Oncology and Gender Medicine – Moving Forward, Slowly but Surely
healthbook TIMES Oncology Hematology
1Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), CH-1011, Switzerland
2International Cancer Prevention Institute, Epalinges, CH-1066, Switzerland
*corresponding authors
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Gastrointestinal CancerFurther Publications
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
healthbook TIMES Oncology Hematology
Corresponding author:
Dr Alexander Siebenhüner
Senior Consultant in Medical Oncology
Cantonal Hospital Schaffhausen
Schaffhausen, Switzerland
Further Publications
Precision Oncology for Hepato-Pancreato-Biliary (HPB) Cancers: State of the Art and Future Directions
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
1Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
*equal contribution
Breast Cancer
Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study
Eur J Cancer
Lüftner D, Tesch H, Schmidt M, Hartkopf AD, Streicher S, Resch A, Genovese L, Rosé C, Valenti R, Harbeck N
doi: 10.1016/j.ejca.2021.03.045
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
Lancet Oncol.
Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY; Response Assessment in Neuro-Oncology (RANO) group
doi: 10.1016/
Further Publications
Clinical Application of Computational Methods in Precision Oncology: A Review
JAMA Oncol.
Panagiotou OA, Högg LH, Hricak H, Khleif SN, Levy MA, Magnus D, Murphy MJ, Patel B, Winn RA, Nass SJ, Gatsonis C, Cogle CR
doi: 10.1001/jamaoncol.2020.1247.
Further Publications
Neither Last nor Least: Integration of Early Palliative Care Into Standard Oncology Care
healthbook TIMES Oncology Hematology
Kunz R.
doi: 10.36000/hbT.OH.2020.04.014
Further Publications
Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: A Meta-analysis of Randomized Clinical Trials
JAMA Oncol.
Saluja R, Everest L, Cheng S, Cheung M, Chan KKW
doi: 10.1001/jamaoncol.